KNAW

Research

Phase I dose escalation study of Cisplatin, Pemetrexed and Radiotherapy...

Pagina-navigatie:


Update content


Title Phase I dose escalation study of Cisplatin, Pemetrexed and Radiotherapy for inoperable stage III non-small-cell lung cancer (NSCLC)
Period 06 / 2005 - 05 / 2007
Status Completed
Research number OND1317721
Data Supplier Website CCMO

Related organisations

Related people

Project leader Dr. R.J. van Klaveren

Classification

D23120 Oncology
D23220 Internal medicine
D23340 Biopharmacology, toxicology

Go to page top
Go back to contents
Go back to site navigation